Goran Rakić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Goran Rakić has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Anna Uram-Benka
Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia
3 shared publications Biljana Draskovic
Institute for the Healthcare of Children and Youth of Vojvodina, Novi Sad + Faculty of Medicine, Novi Sad
3 shared publications- Biljana Drašković
University of Novi Sad, Faculty of Medicine, Novi Sad
3 shared publications Danica Stanic
Institute for the healthcare of children and youth of Vojvodina, Clinic of pediatric surgery, Department of anesthesiology, intensive care and pain therapy, Novi Sad
3 shared publications- Dragan Turanjanin
University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia + Institute for Child and Youth Health Care of Vojvodina, Clinic for Pediatric Surgery, Novi Sad, Serbia
3 shared publications Izabella Fabri
Institute for the Healthcare of Children and Youth of Vojvodina, Novi Sad + Faculty of Medicine, Novi Sad
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 154 (1-2) , 34-39
Comparison of procedural sedation using dexmedetomidine and the combination of dexmedetomidine with S-ketamine during magnetic resonance examination of the endocranium in children
Introduction/Objective. There is an increasing number of children requiring magnetic resonance imaging (MRI) of the brain as a diagnostic procedure. During the scan, it is necessary for the child to remain still for an extended period. This is often challenging due to the patient?s age, as well as the nature of the disease, which often makes them neurologically altered and uncooperative. The aim of this study was to evaluate the quality and safety of procedural sedation in children undergoing MRI of the brain by comparing two different sedation protocols. Methods. The study included 60 participants, aged 1?18 years, who required sedation during MRI of the brain. Using simple randomization, they were divided into two groups: the dexmedetomidine group (DEX group) was sedated with dexmedetomidine, and the dexmedetomidine/S-ketamine (DEX/KES group) received a combination of dexmedetomidine and S-ketamine. Results. Our results showed that the time to achieve adequate sedation was significantly shorter in the DEX/KES group (6.37 ? 3.62 min) compared to the DEX group (9.03 ? 3.48 min) (p = 0.005). During the initial 10 minutes, the average dexmedetomidine dose was identical in both groups (1.59 mcg/kg). However, during the continuous infusion phase until the end of sedation, the average dexmedetomidine dose was 1.47 mcg/kg in the DEX/KES group versus 1.60 mcg/kg in the DEX group. Analysis of hemodynamic parameters showed better stability in the DEX/KES group. Complications occurred more frequently in the DEX group. Conclusion. The dexmedetomidine/S-ketamine group provides a faster onset of sedation, better hemodynamic stability, lower total doses of sedatives, and fewer complications compared to dexmedetomidine alone.
- 1 January 2026
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 154 (1-2) , 34-39
Open AccessComparison of procedural sedation using dexmedetomidine and the combination of dexmedetomidine with S-ketamine during magnetic resonance examination of the endocranium in children
Introduction/Objective. There is an increasing number of children requiring magnetic resonance imaging (MRI) of the brain as a diagnostic procedure. During the scan, it is necessary for the child to remain still for an extended period. This is often challenging due to the patient?s age, as well as the nature of the disease, which often makes them neurologically altered and uncooperative. The aim of this study was to evaluate the quality and safety of procedural sedation in children undergoing MRI of the brain by comparing two different sedation protocols. Methods. The study included 60 participants, aged 1?18 years, who required sedation during MRI of the brain. Using simple randomization, they were divided into two groups: the dexmedetomidine group (DEX group) was sedated with dexmedetomidine, and the dexmedetomidine/S-ketamine (DEX/KES group) received a combination of dexmedetomidine and S-ketamine. Results. Our results showed that the time to achieve adequate sedation was significantly shorter in the DEX/KES group (6.37 ? 3.62 min) compared to the DEX group (9.03 ? 3.48 min) (p = 0.005). During the initial 10 minutes, the average dexmedetomidine dose was identical in both groups (1.59 mcg/kg). However, during the continuous infusion phase until the end of sedation, the average dexmedetomidine dose was 1.47 mcg/kg in the DEX/KES group versus 1.60 mcg/kg in the DEX group. Analysis of hemodynamic parameters showed better stability in the DEX/KES group. Complications occurred more frequently in the DEX group. Conclusion. The dexmedetomidine/S-ketamine group provides a faster onset of sedation, better hemodynamic stability, lower total doses of sedatives, and fewer complications compared to dexmedetomidine alone.
- Open Access
- 1 January 2025
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 44 (5) , 1110-1117
Effects of propofol and sevoflurane on metabolic changes and oxidative stress markers in laparoscopic appendectomy in children: Clinical control trial
Background: Laparoscopic appendectomy offers several advantages over open surgery, including shorter recovery time and less postoperative pain. However, it also poses some risks due to the creation of pneumoperitoneum. Understanding and mitigating this risk through the use of appropriate anaesthetic agents, antioxidant therapy, and optimised surgical techniques can improve patient outcomes. This study aimed to determine which of the two anaesthetics, propofol or sevoflurane, provides better suppression of oxidative, inflammatory and metabolic responses in children undergoing laparoscopic or conventional appendectomy. Methods: This randomised, clinical control trial enrolled 120 children aged 7 to 17 years with a diagnosis of acute appendicitis. Key parameters, including blood glucose, white blood cells, IL-6, oxidative stress markers, lactate, pH, and mean arterial pressure, were analysed. Results: A statistically significant change in lactate and mean arterial pressure values was observed over time in all four study groups. However, neither the type of surgical procedure nor the type of anaesthesia significantly influenced glucose, white blood cells or thiobarbituric acid levels. The postoperative values of IL-6 were lower in patients treated with balanced anaesthesia. Conclusions: Our study demonstrated that the type of anaesthesia affects hemodynamic changes, which are closely related to the occurrence of reperfusion injury. Although markers of tissue hypoxia and acidosis were elevated during laparoscopic surgery, their values quickly normalised in the immediate postoperative period.
- 1 January 2025
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 44 (5) , 1110-1117
Open AccessEffects of propofol and sevoflurane on metabolic changes and oxidative stress markers in laparoscopic appendectomy in children: Clinical control trial
Background: Laparoscopic appendectomy offers several advantages over open surgery, including shorter recovery time and less postoperative pain. However, it also poses some risks due to the creation of pneumoperitoneum. Understanding and mitigating this risk through the use of appropriate anaesthetic agents, antioxidant therapy, and optimised surgical techniques can improve patient outcomes. This study aimed to determine which of the two anaesthetics, propofol or sevoflurane, provides better suppression of oxidative, inflammatory and metabolic responses in children undergoing laparoscopic or conventional appendectomy. Methods: This randomised, clinical control trial enrolled 120 children aged 7 to 17 years with a diagnosis of acute appendicitis. Key parameters, including blood glucose, white blood cells, IL-6, oxidative stress markers, lactate, pH, and mean arterial pressure, were analysed. Results: A statistically significant change in lactate and mean arterial pressure values was observed over time in all four study groups. However, neither the type of surgical procedure nor the type of anaesthesia significantly influenced glucose, white blood cells or thiobarbituric acid levels. The postoperative values of IL-6 were lower in patients treated with balanced anaesthesia. Conclusions: Our study demonstrated that the type of anaesthesia affects hemodynamic changes, which are closely related to the occurrence of reperfusion injury. Although markers of tissue hypoxia and acidosis were elevated during laparoscopic surgery, their values quickly normalised in the immediate postoperative period.
- Open Access
- 1 January 2024
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 77 (9-12) , 348-351
Using low doses of dexmedetomidine for procedural sedation during MRI diagnostics in children - case report
Introduction. Dexmedetomidine is a potent and highly selective ?2-adrenergic agonist. Its sedative effects are mediated through the inhibition of neuronal activity in the locus coeruleus, which is rich in ?2A-adrenergic receptors. In pediatric patients, sedation or general anesthesia is often required for certain diagnostic procedures, such as magnetic resonance imaging, due to limited cooperation in children under six years of age and the intense noise during scanning, ensuring patient tolerance and procedural success. Case Report. We present the case of a five-yearold boy referred for magnetic resonance imaging due to headaches and dizziness. Premedication was administered intramuscularly 30 minutes before the procedure, consisting of atropine (0.0125 mg/kg) and midazolam (0.1 mg/kg). Simultaneously, an initial intravenous bolus of dexmedetomidine (2 ?g/kg) was infused over 15 minutes. The child was then transferred to the magnetic resonance imaging room, where sedation was maintained with a continuous intravenous infusion of dexmedetomidine at 0.25 ?g/kg/h via an infusion pump, without additional anesthetic agents or bolus doses. No adverse effects, including bradycardia, respiratory disturbances, or desaturation were observed. Conclusion. Despite the use of a subminimal continuous dexmedetomidine dose compared to recommended dosing regimens, an adequate depth of sedation was achieved, allowing for high-quality magnetic resonance imaging without complications.
- 1 January 2024
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 77 (9-12) , 348-351
Open AccessUsing low doses of dexmedetomidine for procedural sedation during MRI diagnostics in children - case report
Introduction. Dexmedetomidine is a potent and highly selective ?2-adrenergic agonist. Its sedative effects are mediated through the inhibition of neuronal activity in the locus coeruleus, which is rich in ?2A-adrenergic receptors. In pediatric patients, sedation or general anesthesia is often required for certain diagnostic procedures, such as magnetic resonance imaging, due to limited cooperation in children under six years of age and the intense noise during scanning, ensuring patient tolerance and procedural success. Case Report. We present the case of a five-yearold boy referred for magnetic resonance imaging due to headaches and dizziness. Premedication was administered intramuscularly 30 minutes before the procedure, consisting of atropine (0.0125 mg/kg) and midazolam (0.1 mg/kg). Simultaneously, an initial intravenous bolus of dexmedetomidine (2 ?g/kg) was infused over 15 minutes. The child was then transferred to the magnetic resonance imaging room, where sedation was maintained with a continuous intravenous infusion of dexmedetomidine at 0.25 ?g/kg/h via an infusion pump, without additional anesthetic agents or bolus doses. No adverse effects, including bradycardia, respiratory disturbances, or desaturation were observed. Conclusion. Despite the use of a subminimal continuous dexmedetomidine dose compared to recommended dosing regimens, an adequate depth of sedation was achieved, allowing for high-quality magnetic resonance imaging without complications.
- Open Access
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Serbian Journal of Anesthesia and Intensive Therapy
- Vol. 46 (5-6) , 105-119
Airway management in neonates and infants: Recommendations
Tracheal intubation is one of the most frequently performed medical procedures in neonatal intensive care units. Younger children, pre-term and full-term infants are at the highest risk of respiratory and traumatic complications when securing the airway. A difficult airway implies a clinical situation in which difficult airway management occurs by an experienced specialist. It is recommended to apply an adequate depth of sedation or general anesthesia with muscle relaxation in neonates and infants during the airway management in order to ensure the comfort and safety of the patients. The use of a videolaryngoscope with standard blades (Macintosh and Miller) is recommended for securing the airway, especially in neonates and infants. Use of passive oxygenation during tracheal intubation prolongs the safe duration of apnea, increases functional residual capacity and reduces the incidence of hypoxemia. The use of supraglottic airway device for rescue ventilation and oxygenation is advised if tracheal intubation has failed and ventilation with a face mask is inadequate. Limiting the number of tracheal intubation attempts is recommended. If two or fewer laryngoscopies are unsuccessful, operator should switch to indirect methods for intubation. After four attempts, intubators should stop and wake the child. It is advised to immediately check the position of the tube simultaneously with clinical signs and the appearance of sustainable carbon dioxide curve. Assessment of clinical indicators is necessary to predict successful awake extubation. A tidal volume greater than 5 ml/kg may indicate readiness for extubation.
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Serbian Journal of Anesthesia and Intensive Therapy
- Vol. 46 (5-6) , 105-119
Open AccessAirway management in neonates and infants: Recommendations
Tracheal intubation is one of the most frequently performed medical procedures in neonatal intensive care units. Younger children, pre-term and full-term infants are at the highest risk of respiratory and traumatic complications when securing the airway. A difficult airway implies a clinical situation in which difficult airway management occurs by an experienced specialist. It is recommended to apply an adequate depth of sedation or general anesthesia with muscle relaxation in neonates and infants during the airway management in order to ensure the comfort and safety of the patients. The use of a videolaryngoscope with standard blades (Macintosh and Miller) is recommended for securing the airway, especially in neonates and infants. Use of passive oxygenation during tracheal intubation prolongs the safe duration of apnea, increases functional residual capacity and reduces the incidence of hypoxemia. The use of supraglottic airway device for rescue ventilation and oxygenation is advised if tracheal intubation has failed and ventilation with a face mask is inadequate. Limiting the number of tracheal intubation attempts is recommended. If two or fewer laryngoscopies are unsuccessful, operator should switch to indirect methods for intubation. After four attempts, intubators should stop and wake the child. It is advised to immediately check the position of the tube simultaneously with clinical signs and the appearance of sustainable carbon dioxide curve. Assessment of clinical indicators is necessary to predict successful awake extubation. A tidal volume greater than 5 ml/kg may indicate readiness for extubation.
- Open Access
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in ABC - casopis urgentne medicine
- Vol. 23 (2) , 12-16
The most common causes of dyspneia in children
Introduction: Respiratory diseases account for more than 25% of all pediatric examinations. The most common are asthma, acute bronchitis and respiratory infections. They are mostly accompanied by dyspnea, increased body temperature and cough. Objective: To examine the frequency, age differences and seasonal nature of respiratory diseases in the pediatric age. Materials and methods: The data were analyzed retrospectively, using the electronic database of the Novi Sad Emergency Medical Service (EMSNS) in the period from July 1, 2022 to July 1, 2023. The research included pediatric patients diagnosed with laryngitis (J04 according to ICD-10), acute bronchitis (J20 according to ICD-10), asthma (J45 according to ICD-10) and pneumonia (J18 according to ICD-10). 11259 patients of both sexes were analyzed. For data analysis we used descriptive statistical methods and standard deviation. Results: Out of a total of 11,259 examined children, 840 (7%) of them presented with respiratory problems. Of these, there were 519 (62%) boys and 321 (38%) girls. The average age of the children was 4 years (SD ± 3.2). The majority of children examined were aged 0-5 - 644 (77%). 472 (56%) children were diagnosed with laryngitis, 267 (32%) children had acute bronchitis, 81 (10%) children had asthma, 20 children (2%) had pneumonia. Most children were examined in October - 135 (16%), most often due to laryngitis - 73 (54%). 765 (91%) were treated on the spot, while 75 (9%) of them were referred to the IZZDIOV, of which 33 (44%) children were referred for acute bronchitis. The most frequently used therapy was Methylprednisolone - 368 (46%), mostly in 202 (24%) children diagnosed with laryngitis. Conclusion: Prevention, early diagnosis and therapy are necessary in order to prevent more serious complications of these diseases.
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in ABC - casopis urgentne medicine
- Vol. 23 (2) , 12-16
Open AccessThe most common causes of dyspneia in children
Introduction: Respiratory diseases account for more than 25% of all pediatric examinations. The most common are asthma, acute bronchitis and respiratory infections. They are mostly accompanied by dyspnea, increased body temperature and cough. Objective: To examine the frequency, age differences and seasonal nature of respiratory diseases in the pediatric age. Materials and methods: The data were analyzed retrospectively, using the electronic database of the Novi Sad Emergency Medical Service (EMSNS) in the period from July 1, 2022 to July 1, 2023. The research included pediatric patients diagnosed with laryngitis (J04 according to ICD-10), acute bronchitis (J20 according to ICD-10), asthma (J45 according to ICD-10) and pneumonia (J18 according to ICD-10). 11259 patients of both sexes were analyzed. For data analysis we used descriptive statistical methods and standard deviation. Results: Out of a total of 11,259 examined children, 840 (7%) of them presented with respiratory problems. Of these, there were 519 (62%) boys and 321 (38%) girls. The average age of the children was 4 years (SD ± 3.2). The majority of children examined were aged 0-5 - 644 (77%). 472 (56%) children were diagnosed with laryngitis, 267 (32%) children had acute bronchitis, 81 (10%) children had asthma, 20 children (2%) had pneumonia. Most children were examined in October - 135 (16%), most often due to laryngitis - 73 (54%). 765 (91%) were treated on the spot, while 75 (9%) of them were referred to the IZZDIOV, of which 33 (44%) children were referred for acute bronchitis. The most frequently used therapy was Methylprednisolone - 368 (46%), mostly in 202 (24%) children diagnosed with laryngitis. Conclusion: Prevention, early diagnosis and therapy are necessary in order to prevent more serious complications of these diseases.
- Open Access
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in ABC - casopis urgentne medicine
- Vol. 23 (1) , 13-25
Prehospital care of injured patients in a mass casualty incidents
Mass accidents do not happen often, but when they do, they cause a significant disruption in the functioning of a society with a large number of casualties and an increased percentage of deaths among the injured. The aim of the work is to present the way of organization within the emergency medical aid service in the event of a mass accident. Numerous services are involved in caring for the injured, so their mutual cooperation is important, as is the functioning within each service. Depending on the type of event, the leader of the intervention should be from the service that is responsible for the nature of the event. He is in charge of organizing the entire intervention. All the services that participate in care have their own leader who communicates with the leader of the intervention. Within the Emergency Medical Service, the triage leader and the transport leader play an important role. The triage leader is in charge of primary triage. It uses simple triage algorithms to triage the injured according to the urgency of care in four categories in the shortest possible time. After primary triage, secondary triage and treatment of the injured is in process. Only necessary measures to stabilize the injured are taken during this phase. The transport of the injured takes place based on the priority and the type of transport that is needed. During the whole treatment process, the injured must be marked with triage cards. Based on them,we can later conduct the documentation: total number of injured, number of injured by triage categories, care measures taken, method and time of transport. In order for the services to provide the best care for injured in a mass accident, the existence of unique protocols at the level of one country is necessary. In addition to protocols, education and training of employees are necessary, not only in the emergency medical service, but in all services that participate in caring for the injured. Best way to do this is shared training of employees from several departments. Only in this way can the available resources be used in the most optimal way to take care of the largest number of injured people in the best possible way and in the shortest possible time.
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in ABC - casopis urgentne medicine
- Vol. 23 (1) , 13-25
Open AccessPrehospital care of injured patients in a mass casualty incidents
Mass accidents do not happen often, but when they do, they cause a significant disruption in the functioning of a society with a large number of casualties and an increased percentage of deaths among the injured. The aim of the work is to present the way of organization within the emergency medical aid service in the event of a mass accident. Numerous services are involved in caring for the injured, so their mutual cooperation is important, as is the functioning within each service. Depending on the type of event, the leader of the intervention should be from the service that is responsible for the nature of the event. He is in charge of organizing the entire intervention. All the services that participate in care have their own leader who communicates with the leader of the intervention. Within the Emergency Medical Service, the triage leader and the transport leader play an important role. The triage leader is in charge of primary triage. It uses simple triage algorithms to triage the injured according to the urgency of care in four categories in the shortest possible time. After primary triage, secondary triage and treatment of the injured is in process. Only necessary measures to stabilize the injured are taken during this phase. The transport of the injured takes place based on the priority and the type of transport that is needed. During the whole treatment process, the injured must be marked with triage cards. Based on them,we can later conduct the documentation: total number of injured, number of injured by triage categories, care measures taken, method and time of transport. In order for the services to provide the best care for injured in a mass accident, the existence of unique protocols at the level of one country is necessary. In addition to protocols, education and training of employees are necessary, not only in the emergency medical service, but in all services that participate in caring for the injured. Best way to do this is shared training of employees from several departments. Only in this way can the available resources be used in the most optimal way to take care of the largest number of injured people in the best possible way and in the shortest possible time.
- Open Access
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Serbian Journal of Anesthesia and Intensive Therapy
- Vol. 45 (7-8) , 93-105
S(+)-ketamin: Review of pharmacological properties and use in clinical practice (S(+)-ketamin: Pharmacology and clinical use)
Ketamine is a phenylcyclidine derivative that was first synthesized in 1962, and it was approved for clinical use in 1970. The racemic mixture of ketamine consists of two optical isomers -R(-)-enantiomer and S(+)-enantiomer. S-isomer is twice as potent as the racemic mixture, it is eliminated faster, resulting in a shorter active period of the drug and faster recovery time. It affects the body through the N-methyl-D-aspartate receptor as well as numerous other receptors of neurotransmitter systems. S(+)-keta-mine, similarly to racemic mixture of ketamine, leads to stimulation of the cardiovascular system, bronchodilation, inhibition of the inflammatory response and the dissociative anesthesia. It is mainly used in the pediatric population, due to the lower frequency of adverse effects, especially psychomimetic phenomena. It is used for induction and maintenance of general anesthesia as well as for procedural sedation. Due to its potent analgesic effect, it is used to relieve postoperative pain, neuropathic pain, and there are reports of successful control of cancer-resistant pain. Although the question of the influence of esketamine on intracranial pressure is controversial, with adequate co-med-ication, esketamine can lead to a successful lowering of intracranial pressure. Due to its good hemodynamic stability and analgesia, S(+)-ketamine is probably the anesthetic/ sedative of first choice in burn patients. Other indications are: status asthmaticus, status epilepticus, antidepressant effect, sedation in intensive care units, sedation for short surgical interventions, etc. Co-medication is advised, especially with benzodiazepines, the most common of which is midazolam.
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Serbian Journal of Anesthesia and Intensive Therapy
- Vol. 45 (7-8) , 93-105
Open AccessS(+)-ketamin: Review of pharmacological properties and use in clinical practice (S(+)-ketamin: Pharmacology and clinical use)
Ketamine is a phenylcyclidine derivative that was first synthesized in 1962, and it was approved for clinical use in 1970. The racemic mixture of ketamine consists of two optical isomers -R(-)-enantiomer and S(+)-enantiomer. S-isomer is twice as potent as the racemic mixture, it is eliminated faster, resulting in a shorter active period of the drug and faster recovery time. It affects the body through the N-methyl-D-aspartate receptor as well as numerous other receptors of neurotransmitter systems. S(+)-keta-mine, similarly to racemic mixture of ketamine, leads to stimulation of the cardiovascular system, bronchodilation, inhibition of the inflammatory response and the dissociative anesthesia. It is mainly used in the pediatric population, due to the lower frequency of adverse effects, especially psychomimetic phenomena. It is used for induction and maintenance of general anesthesia as well as for procedural sedation. Due to its potent analgesic effect, it is used to relieve postoperative pain, neuropathic pain, and there are reports of successful control of cancer-resistant pain. Although the question of the influence of esketamine on intracranial pressure is controversial, with adequate co-med-ication, esketamine can lead to a successful lowering of intracranial pressure. Due to its good hemodynamic stability and analgesia, S(+)-ketamine is probably the anesthetic/ sedative of first choice in burn patients. Other indications are: status asthmaticus, status epilepticus, antidepressant effect, sedation in intensive care units, sedation for short surgical interventions, etc. Co-medication is advised, especially with benzodiazepines, the most common of which is midazolam.
- Open Access
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Galenika Medical Journal
- Vol. 2 (7) , 27-33
Corticosteroid use in critically ill patients
The use of corticosteroids as immunosuppressants in critically ill patients is a very complex issue. These potent immunomodulators can be used in the treatment of critically ill patients with severe community-acquired pneumonia (SCAP) and/or septic shock. Local and systemic inflammatory responses are increased in SCAP, thus impairing gas exchange. Also, persistent inflammatory response is associated with higher mortality in patients with COVID-19 and non-COVID-19-related ARDS. However, the risk of administering systemic steroids (methylprednisolone, Dexamethasone, hydrocortisone, etc.) to non-responders is evident. In general, the use of corticosteroids in critically ill patients should not be routine (one size fits all approach) but as personalized and individualized as clinically possible (from one size does not fit all to one size fits one).
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Galenika Medical Journal
- Vol. 2 (7) , 27-33
Open AccessCorticosteroid use in critically ill patients
The use of corticosteroids as immunosuppressants in critically ill patients is a very complex issue. These potent immunomodulators can be used in the treatment of critically ill patients with severe community-acquired pneumonia (SCAP) and/or septic shock. Local and systemic inflammatory responses are increased in SCAP, thus impairing gas exchange. Also, persistent inflammatory response is associated with higher mortality in patients with COVID-19 and non-COVID-19-related ARDS. However, the risk of administering systemic steroids (methylprednisolone, Dexamethasone, hydrocortisone, etc.) to non-responders is evident. In general, the use of corticosteroids in critically ill patients should not be routine (one size fits all approach) but as personalized and individualized as clinically possible (from one size does not fit all to one size fits one).
- Open Access
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Galenika Medical Journal
- Vol. 2 (5) , 14-22
Antibiotic treatment of critically ill patients with sepsis: From FK/FD to novel drugs
Early detection of sepsis and its severity is critical for initiating proper therapy, including antibiotics, as soon as possible to maximize survival chances. Understanding the pathophysiological changes in septic shock that impact antimicrobial pharmacokinetics and pharmacodynamics (PK/PD), understanding the basics of PK/PD, and knowing PK-PD strategies in septic shock patients are all critical for appropriate therapy. By definition multi-drug resistant (MDR) microorganisms are those with acquired non-susceptibility to at least one agent in three or more antimicrobial categories. In the race between bacteria and novel antibiotics development, unfortunately, the number of new antibiotics/indications is not keeping pace with resistance and needs, especially for MDR Gram-negative microorganisms. When we fast forward to the approved antibiotics in the last five years, the list is rather short. Lefamulin is a novel pleuromutilin antibiotic which manifests activity against most Gram-positive pathogens. Cefiderocol is an injectable siderophore cephalosporin. Like other b-lactam antibiotics, it inhibits Gram-negative bacterial cell wall formation by binding to penicillin-binding proteins. Imipenem/cilastatin/relebactam is a new b-lactam/b-lactamase inhibitor combination with activity against MDR Gram-negative bacteria, including many CRE but excluding Metallo-b-lactamase (MBL)-producing Enterobacterales and CRAB. Those three antibiotics were FDA approved in 2019 and European Medicines Agency (EMA) approved in 2020. Plazomicin is a new semisynthetic aminoglycoside with activity against several MDR Gram-negative organisms, including CRE (FDA-approved in 2018). Meropenem-vaborbactam is a fixed-dose combination product of a carbapenem and a cyclic boronic acid b-lactamase inhibitor with potent activity against resistant Gram-negative bacteria like Klebsiella pneumoniae carbapenemase (KPC)-producing CRE; it is inactive against CRAB (FDA-approved in 2017; EMA-approved in 2018). Eravacycline is a new completely synthesized fluorocycline. It has a high level of effectiveness against Grampositive and Gram-negative bacterial strains that have developed tetracycline-specific resistance mechanisms; it is inactive against Pseudomonas aeruginosa (FDAand EMA-approved in 2018). Concluding this list of recently approved antibiotics is omadacycline, novel aminomethylcycline and a derivative of minocycline, with a chemical structure similar to tigecycline. Like other tetracyclines, omadacycline inhibits bacterial protein synthesis and possesses broad-spectrum antibacterial activity against Gram-positive and Gram-negative aerobic, anaerobic, and atypical bacteria including CRAB. It is inactive against Pseudomonas aeruginosa (FDA-approved in 2018). There are three novel carbapenems sulopenem, tebipenem pivoxil hydrobromide and benapenem. There is a group of antibiotics in phase III clinical trials: the combination aztreonam/ avibactam, sulbactam/durlobactam, cefepime/enmetazobactam, cefepime/zidebactam, cefepime/taniborbactam. An interesting approach to antimicrobial treatment is antimicrobial drug repurposing. Drug combinations could be a strategy to extend the life of antibiotics in the XXI century due to the multi-targeting mechanisms of agents. New active substances are urgently required to stop the spread of antibiotic-resistant bacteria. However, it could be a rather cumbersome and expensive procedure. Antimicrobial misuse and/or overuse contribute greatly to this very important global healthcare problem.
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Galenika Medical Journal
- Vol. 2 (5) , 14-22
Open AccessAntibiotic treatment of critically ill patients with sepsis: From FK/FD to novel drugs
Early detection of sepsis and its severity is critical for initiating proper therapy, including antibiotics, as soon as possible to maximize survival chances. Understanding the pathophysiological changes in septic shock that impact antimicrobial pharmacokinetics and pharmacodynamics (PK/PD), understanding the basics of PK/PD, and knowing PK-PD strategies in septic shock patients are all critical for appropriate therapy. By definition multi-drug resistant (MDR) microorganisms are those with acquired non-susceptibility to at least one agent in three or more antimicrobial categories. In the race between bacteria and novel antibiotics development, unfortunately, the number of new antibiotics/indications is not keeping pace with resistance and needs, especially for MDR Gram-negative microorganisms. When we fast forward to the approved antibiotics in the last five years, the list is rather short. Lefamulin is a novel pleuromutilin antibiotic which manifests activity against most Gram-positive pathogens. Cefiderocol is an injectable siderophore cephalosporin. Like other b-lactam antibiotics, it inhibits Gram-negative bacterial cell wall formation by binding to penicillin-binding proteins. Imipenem/cilastatin/relebactam is a new b-lactam/b-lactamase inhibitor combination with activity against MDR Gram-negative bacteria, including many CRE but excluding Metallo-b-lactamase (MBL)-producing Enterobacterales and CRAB. Those three antibiotics were FDA approved in 2019 and European Medicines Agency (EMA) approved in 2020. Plazomicin is a new semisynthetic aminoglycoside with activity against several MDR Gram-negative organisms, including CRE (FDA-approved in 2018). Meropenem-vaborbactam is a fixed-dose combination product of a carbapenem and a cyclic boronic acid b-lactamase inhibitor with potent activity against resistant Gram-negative bacteria like Klebsiella pneumoniae carbapenemase (KPC)-producing CRE; it is inactive against CRAB (FDA-approved in 2017; EMA-approved in 2018). Eravacycline is a new completely synthesized fluorocycline. It has a high level of effectiveness against Grampositive and Gram-negative bacterial strains that have developed tetracycline-specific resistance mechanisms; it is inactive against Pseudomonas aeruginosa (FDAand EMA-approved in 2018). Concluding this list of recently approved antibiotics is omadacycline, novel aminomethylcycline and a derivative of minocycline, with a chemical structure similar to tigecycline. Like other tetracyclines, omadacycline inhibits bacterial protein synthesis and possesses broad-spectrum antibacterial activity against Gram-positive and Gram-negative aerobic, anaerobic, and atypical bacteria including CRAB. It is inactive against Pseudomonas aeruginosa (FDA-approved in 2018). There are three novel carbapenems sulopenem, tebipenem pivoxil hydrobromide and benapenem. There is a group of antibiotics in phase III clinical trials: the combination aztreonam/ avibactam, sulbactam/durlobactam, cefepime/enmetazobactam, cefepime/zidebactam, cefepime/taniborbactam. An interesting approach to antimicrobial treatment is antimicrobial drug repurposing. Drug combinations could be a strategy to extend the life of antibiotics in the XXI century due to the multi-targeting mechanisms of agents. New active substances are urgently required to stop the spread of antibiotic-resistant bacteria. However, it could be a rather cumbersome and expensive procedure. Antimicrobial misuse and/or overuse contribute greatly to this very important global healthcare problem.
- 1 January 2017
- Published by National Library of Serbia in Acta chirurgica Iugoslavica
- Vol. 64 (1) , 43-47
Traumatic pancreatitis in children
Traumatic pancreatitis is still a relative enigma, despite modern clinical practice, technology and modern diagnostic procedures. This condition is very specific and serious and is associated with significant morbidity, especially in pediatric population. Traumatic pancreatitis is also an emerging problem in pediatric population with its incidence rising in the last 20 years. Data regarding the optimal management and physician practice patterns are lacking. We present a literature review and updates on the management of pediatric pancreatitis due to trauma. Prospective multicenter studies are necessary to guide care and improve outcomes for this population.
- 1 January 2017
- Published by National Library of Serbia in Acta chirurgica Iugoslavica
- Vol. 64 (1) , 43-47
Traumatic pancreatitis in children
Traumatic pancreatitis is still a relative enigma, despite modern clinical practice, technology and modern diagnostic procedures. This condition is very specific and serious and is associated with significant morbidity, especially in pediatric population. Traumatic pancreatitis is also an emerging problem in pediatric population with its incidence rising in the last 20 years. Data regarding the optimal management and physician practice patterns are lacking. We present a literature review and updates on the management of pediatric pancreatitis due to trauma. Prospective multicenter studies are necessary to guide care and improve outcomes for this population.